- Home
- ECPG vs AMLX Comparison
ECPG vs AMLX Comparison
Compare ECPG & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECPG | AMLX |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1999 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ECPG | AMLX |
|---|---|---|
| Price | $55.13 | $16.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $59.50 | $17.43 |
| AVG Volume (30 Days) | 179.1K | ★ 1.7M |
| Earning Date | 02-25-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,560,869,000.00 | N/A |
| Revenue This Year | $33.17 | N/A |
| Revenue Next Year | $2.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.52 | N/A |
| 52 Week Low | $26.45 | $2.60 |
| 52 Week High | $57.81 | $16.96 |
Technical Indicators
Market Signals| Indicator | ECPG | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 75.12 |
| Support Level | $54.71 | $12.08 |
| Resistance Level | $56.69 | $12.50 |
| Average True Range (ATR) | 1.33 | 0.92 |
| MACD | -0.27 | 0.47 |
| Stochastic Oscillator | 34.99 | 92.46 |
Price Performance
Historical ComparisonAbout ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.